Skip to content

Is Ukrainian Defense-Tech Investable? The Objections, Answered

Yes — but not for the reason the headlines give. The state already buys tens of billions from companies that took under $60M of private venture. Here are the five objections foreign capital raises — war, ownership and getting money out, governance, the exit, “too early” — plus the one nobody wants to answer: what if the war ends.

12 min read
Artur Fedorenko

Author

Artur Fedorenko, Founder & CEO, Wiseboard.

On this page

The technology is proven — combat-tested against a peer adversary in a way no allied market can replicate. What a foreign investor actually weighs is structural: whether the asset can be owned, the war priced, the money moved, and the position exited. This piece takes each of those objections in turn, answers it concretely, and stays honest about the two that don’t fully resolve.

The short answer

Is Ukrainian defense-tech investable? Yes — and the mispricing is real, once you frame it right

Be precise about the gap, because the loose version invites a fair objection. The $35 billion figure is annual production capacity— built from ~$1 billion in 2022 — and most of it is bought by the Ukrainian state and, increasingly, allied governments (roughly $6 billion flowed in via the Danish model and partner procurement in 2025). It is not a private market cap. Set against it, disclosed private venture in 2025 was about $57 million (PitchBook).

So the thesis is not “a $35B market trades at $57M.” It is sharper than that: the customer is already spending tens of billions a year with companies that have taken almost no private equity. You can back a proven supplier to that demand at seed-stage prices — before the private market finds it. That is the mispricing, and it is defensible.

Ukrainian defense-tech — the investability signals
Production capacity, 2025~$35B (from ~$1B in 2022)
Bought mostly bythe state + allies (~$6B foreign gov, Danish model)
Disclosed private venture, 2025~$57.2M (PitchBook) — the gap
First Nasdaq IPOSwarmer · Mar 2026 · a $15M raise (precedent, thin float)
First $1B unicorn (a markup, not an exit)UFORCE · Mar 2026 · profitable
Controlled exportsopened 2026 — demand no longer capped at one buyer

The five objections below are the ones that actually come up in a committee. Three have clean answers; two — repatriation and the end of the war — stay genuinely hard, and I will say so.

Objection 1

“There's a war” — so separate war risk from company risk

The mistake is one blanket number for “Ukraine risk” applied to the whole deal. Investable structures isolate what the war actually threatens and price only that.

  • The value sits offshore. The holding company and the IP live outside Ukraine, so the asset you own is not physically on the front line.
  • Production is distributed. Manufacturing is dispersed across many sites and, increasingly, duplicated with partners abroad — the sector was built decentralized precisely because it is under attack.
  • The team is protected, not drafted. Defense and dual-use companies hold critical-infrastructure status, which reserves their key specialists from mobilization — the state needs them building — with the Defence City regime hardening the sites on top.
  • What remains is priced, not feared. A risk register discounts the specific, bounded exposures — single-site, supply, counterparty, FX — instead of a haircut that mistakes a headline for a model.
Risk register (Ukraine-specific)
A line-by-line inventory of a company's real exposures — single-site production, key-person, currency and repatriation, counterparty — each priced and mitigated. It turns “there's a war” from a reason not to look into a set of discrete, underwritable items.

That is the summary. The full war-risk answer — the structure, the insurance market now covering it, and what a ceasefire actually does to the thesis — is its own piece: is it safe to invest in Ukraine's defense industry?

Objection 2

“Can a foreigner own it — and get money out?” — yes, by design, not by default

A foreign investor does not buy the Ukrainian wartime entity directly. They take equity in a cross-border holding that owns the operating company and its IP — the structure built to be legally held and exited by outside capital. Two defense-specific caveats matter, and they are exactly why the structuring is work, not a formality:

  • Moving the IP offshore is itself export-controlled.Assigning military or dual-use IP to a foreign holding can trigger Ukraine's export-control regime and interagency approval — it has to be done on the right path, not assumed.
  • Getting capital out needs a route. Wartime capital controls restrict dividend repatriation from Ukraine. The answer is to design cash flow around it — export revenue and IP licensing landing at the offshore holding — so returns are not trapped behind the border. This is a real constraint, handled by structure, not wished away.

The mechanics of each route in — direct equity, fund, strategic, non-dilutive — are laid out in the routes-in guide.

Objection 3

“Isn't it too opaque to diligence?” — the bar is normal, and the tooling now exists

The perception is fair; the answer is not a promise but a paper trail that meets an institutional bar before the raise. Ukraine has also built the infrastructure that makes it checkable:

  • Procurement is increasingly transparent — Prozorro and digital defense procurement leave an auditable record of who sells what to the state.
  • Companies are pre-vetted in the ecosystem — Brave1 and the clusters screen and document companies well before they reach an investor.
  • Beneficial ownership and sanctions are screened — the one regional risk that is non-negotiable is Russian-linked capital or supply in the structure; it is checked and cleared, or the deal does not happen.

On top of that sits the ordinary institutional list: clean, separated financials; IP assigned to the company; a documented combat record and contract base — a data room built to survive third-party review. Opacity is precisely what that diligence is there to separate out.

Objection 4

“Is there an exit?” — one is proven, one is emerging, and one is a markup

Be honest here, because overselling it is the fastest way to lose a serious investor. Realized liquidity is early, not deep.

  • Public markets — precedent, not a deep market. In March 2026 Swarmerbecame the first Ukrainian defense-tech company to IPO on Nasdaq (ticker SWMR). It was a small raise — about $15 million — and the several-fold first-day pop reflects a thin float, not a liquid market. What it proves is narrower and still valuable: the public door now opens for a Ukrainian defense company.
  • Strategic M&A — the credible exit today. Primes and platform companies buying combat-proven capability and teams is the quieter, more frequent path, and the one most deals are actually built toward.
  • A priced benchmark, not an exit.UFORCE's $1 billion round (raising $50 million while already profitable, on 450% growth in bookings) is a valuation mark the sector can be measured against — but a primary raise is a markup, not liquidity. Do not count it as one.

That is the summary. The full exit map — the first realized VC exit, the Nasdaq precedent, the secondaries market, and how to structure a company to be sold — is its own piece: how to exit a Ukrainian defense-tech investment.

Objection 5

“It's too early / pre-revenue” — but combat-proven isn't the same as exportable

In most markets “pre-revenue” means unvalidated. Here it is the opposite: a product that has worked against a peer adversary carries proof a lab or a range cannot manufacture — which is why independent testing in Ukraine has become a diligence input in its own right.

But combat-proven is not automatically scalable. The system that wins on the Ukrainian front may not meet allied procurement specs, standards or supply-chain rules. The return lives on the bridge between the two: NATO codification and export-readiness lift the ceiling from a single domestic buyer to allied markets, and a US-eligible structure plus codification opens non-dilutive revenue — OTA and allied-nation programs (and, through a US-domiciled affiliate, SBIR/STTR) pay for the technology without taking equity. Early here does not mean unproven; it means priced before that bridge is built.

The question everyone asks

“What if the war ends?” — the honest bull and bear

This is the question a serious investor asks first and a sell-side deck avoids. It deserves a straight answer, because it decides which companies are actually investable.

The bear case is real. A ceasefire removes the wartime demand surge. Single-product FPV shops selling only to the domestic front face a demand cliff and a valuation reset; some will not survive peace. Pretending otherwise is how you lose money.

The bull case is the pivot, and it is already underway.Exports opened in 2026; Europe is rearming for a decade regardless of Ukraine's front line; combat-proven, codified products are exactly what allied militaries now want to buy; and reconstruction turns much of the dual-use base toward civilian demand. The companies built for a single wartime customer are exposed; the ones built to export a proven product to allied markets are the ones peace rewards. If your thesis needs the war to continue, you have picked the wrong company — which is precisely what the diligence is for.

The dividing line

What makes one Ukrainian company investable — and another not

The sector is investable; not every company in it is. The line is rarely the technology — it is whether these are in place, or can be put in place before the money moves:

  • A cross-border holding a foreign investor can legally own and exit.
  • IP assigned to the company and cleared for offshore structuring — one of the largest single swings in value.
  • A repatriation route — cash flow designed to reach the holding, not trapped by capital controls.
  • An export path mapped — licensing and codification, so revenue is not capped at one customer, and the product survives peace.
  • Key-person and mobilization cover, diversified buyers, and clean, separated financials in a verified data room.
  • A documented combat record — evidence, not anecdote.

A company with these is underwritable today. A company missing them is not un-investable — it is un-prepared, and the distance between the two is work, not fate. Building exactly that — the offshore structure, the export and codification path, the risk register, the data room, independent testing — before a company reaches your committee is the work Wiseboard does on the ground in Ukraine.

FAQ

Frequent questions

Published: 21 July 2026

Share
Capital Brief
Deal-flow to your inbox

No spam. Unsubscribe in one click.

TagsInvestabilityDefense-techWar-riskDue diligenceExitAsset class
For investors

See the deal flow

A screened, diligence-ready pipeline of Ukrainian defense companies — sourced inside the ecosystem, packaged for your committee, and held in a structure you can legally own and exit.

Your privacy

We use cookies to measure how the site is used so we can improve it. Analytics and marketing stay off until you allow them. Cookie policy